Antibodies

The new findings may explain why reinfection with the novel coronavirus appears to be relatively rare

Study identifies the specific types of antibodies that may be driving COVID-19 outcomes in both children and adults

Antibodies that react to both ordinary coronaviruses and SARS-CoV-2 do not neutralize the COVID-19-causing virus

Researchers have designed protein-based biosensors that glow when in contact with the virus or COVID-19 antibodies

The novel antibodies, called nanobodies, attack different parts of the coronavirus simultaneously

Mild cases of COVID-19 have more antibodies that target the novel coronavirus's spike protein than severe cases do

Glycosylation of SARS-CoV-2-specific antibodies may be to blame for this reduced transfer from mother to fetus

Using optical biosensor technology, the test provides quantitative measurements of antibodies in less than 20 minutes

Heparan sulfate is increasingly recognized as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 coronavirus pandemic

Antibodies created in response to common cold coronaviruses can target a subunit of the SARS-CoV-2 spike protein